TSCAN THERAPEUTICS, INC. (TCRX) Net margin 2020–2025
TSCAN THERAPEUTICS, INC. (TCRX) net profit margin by fiscal year — reported net income divided by reported revenue.
-1256.8%FY2025 · since FY2020: -2408.0% → -1256.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1256.8% | +3270.8 pp |
| FY2024 | -4527.7% | -4103.8 pp |
| FY2023 | -423.9% | +65.4 pp |
| FY2022 | -489.3% | -9.8 pp |
| FY2021 | -479.5% | +1928.5 pp |
| FY2020 | -2408.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice